Scott is a Professor of Neurology, Harvard Medical School, and Director, Neurofibromatosis Clinic, Massachusetts General Hospital(MGH). Scott is also Chief of Neuro-Oncology at MGH. He provides clinical care for patients with NF1, NF2, Scwhannomatosis and other disorders. He has led numerous clinical trial in the Neurofibromatoses. Scott is currently Co-Chair of Research Endpoints in Neurofibromatosis and Schwannomatosis (REiNS), an NIH sponsored group focused on the development of trial and endpoint development for the Neurofibromatoses. He is a key opinion leader in neurofibromatosis clinical trials and research and has published extensively on his work.